Literature DB >> 17875646

Retinoic acid receptor isotype specificity in F9 teratocarcinoma stem cells results from the differential recruitment of coregulators to retinoic response elements.

Robert F Gillespie1, Lorraine J Gudas2.   

Abstract

The retinoic acid receptor (RAR) alpha, beta(2), and gamma isotypes each regulate specific subsets of target genes in F9 teratocarcinoma stem cells. We used chromatin immunoprecipitation assays to monitor the association of RARgamma, retinoic X receptor (RXR) alpha, and coregulators with the RARbeta(2), Hoxa1, and Cyp26A1 retinoic acid response elements (RAREs) in F9 wild type and RARalpha, -beta(2), and -gamma null cells. Additionally we quantitatively monitored expression of the corresponding mRNAs. We demonstrated that the association of RARgamma and/or RXRalpha with a RARE was not sufficient for retinoic acid (RA)-mediated transcription of the corresponding target gene. However, the ability of RARgamma and/or RXRalpha to recruit pCIP (AIB1/ACTR/RAC-3/TRAM-1/SRC-3) and p300 to a RARE did correlate with RA-associated transcription of target mRNAs. Therefore, the specific functions of the RAR isotypes do not manifest at the level of their DNA binding but rather from a differential ability to recruit specific components of the transcriptional machinery. We also demonstrated that RA-mediated displacement of the polycomb group protein SUZ12 from a RARE was inhibited in the absence of RARgamma. Thus, transcriptional components of the RAR signaling pathway are specifically required for displacement of SUZ12 from RAREs during RA-mediated differentiation of F9 cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875646     DOI: 10.1074/jbc.M704845200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  CARM1 (PRMT4) Acts as a Transcriptional Coactivator during Retinoic Acid-Induced Embryonic Stem Cell Differentiation.

Authors:  Cynthia M Quintero; Kristian B Laursen; Nigel P Mongan; Minkui Luo; Lorraine J Gudas
Journal:  J Mol Biol       Date:  2018-08-25       Impact factor: 5.469

2.  Combination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.

Authors:  Xiao-Han Tang; Kwame Osei-Sarfo; Alison M Urvalek; Tuo Zhang; Theresa Scognamiglio; Lorraine J Gudas
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-03       Impact factor: 11.205

3.  A DNA methyltransferase inhibitor and all-trans retinoic acid reduce oral cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.

Authors:  Xiao-Han Tang; Martin Albert; Theresa Scognamiglio; Lorraine J Gudas
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01

Review 4.  Vitamin A and retinoid signaling: genomic and nongenomic effects.

Authors:  Ziad Al Tanoury; Aleksandr Piskunov; Cécile Rochette-Egly
Journal:  J Lipid Res       Date:  2013-02-24       Impact factor: 5.922

Review 5.  The roles of retinoic acid and retinoic acid receptors in inducing epigenetic changes.

Authors:  Alison Urvalek; Kristian Bruun Laursen; Lorraine J Gudas
Journal:  Subcell Biochem       Date:  2014

6.  Gene expression profiling elucidates a specific role for RARgamma in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells.

Authors:  Dan Su; Lorraine J Gudas
Journal:  Biochem Pharmacol       Date:  2007-11-22       Impact factor: 5.858

7.  Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment.

Authors:  Trisha S Tavares; David Nanus; Ximing J Yang; Lorraine J Gudas
Journal:  Cancer Biol Ther       Date:  2008-10-09       Impact factor: 4.742

8.  The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation.

Authors:  Hanane Boukarabila; Andrew J Saurin; Eric Batsché; Noushine Mossadegh; Maarten van Lohuizen; Arie P Otte; Jacques Pradel; Christian Muchardt; Michael Sieweke; Estelle Duprez
Journal:  Genes Dev       Date:  2009-05-15       Impact factor: 11.361

9.  Retinoic acid-stimulated sequential phosphorylation, PML recruitment, and SUMOylation of nuclear receptor TR2 to suppress Oct4 expression.

Authors:  Pawan Gupta; Ping-Chih Ho; Md Mostaqul Huq; Sung Gil Ha; Sung Wook Park; Amjad Ali Khan; Nien-Pei Tsai; Li-Na Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-05       Impact factor: 11.205

10.  Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin.

Authors:  Karen A M Kennedy; Tammy Porter; Virja Mehta; Scott D Ryan; Feodor Price; Vian Peshdary; Christina Karamboulas; Josée Savage; Thomas A Drysdale; Shun-Cheng Li; Steffany A L Bennett; Ilona S Skerjanc
Journal:  BMC Biol       Date:  2009-10-08       Impact factor: 7.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.